- Research article
- Open Access
Genomic organization of ATOX1, a human copper chaperone
© Liu et al; licensee BioMed Central Ltd. 2003
- Received: 5 November 2002
- Accepted: 5 February 2003
- Published: 5 February 2003
Copper is an essential trace element that plays a critical role in the survival of all living organisms. Menkes disease and occipital horn syndrome (OHS) are allelic disorders of copper transport caused by defects in a X-linked gene (ATP7A) that encodes a P-type ATPase that transports copper across cellular membranes, including the trans-Golgi network. Genetic studies in yeast recently revealed a new family of cytoplasmic proteins called copper chaperones which bind copper ions and deliver them to specific cellular pathways. Biochemical studies of the human homolog of one copper chaperone, ATOX1, indicate direct interaction with the Menkes/OHS protein. Although no disease-associated mutations have been reported in ATOX1, mice with disruption of the ATOX1 locus demonstrate perinatal mortality similar to that observed in the brindled mice (Mobr), a mouse model of Menkes disease. The cDNA sequence for ATOX1 is known, and the genomic organization has not been reported.
We determined the genomic structure of ATOX1. The gene contains 4 exons spanning a genomic distance of approximately 16 kb. The translation start codon is located in the 3' end of exon 1 and the termination codon in exon 3. We developed a PCR-based assay to amplify the coding regions and splice junctions from genomic DNA. We screened for ATOX1 mutations in two patients with classical Menkes disease phenotypes and one individual with occipital horn syndrome who had no alterations detected in ATP7A, as well as an adult female with chronic anemia, low serum copper and evidence of mild dopamine-beta-hydroxylase deficiency and no alterations in the ATOX1 coding or splice junction sequences were found.
In this study, we characterized the genomic structure of the human copper chaperone ATOX1 to facilitate screening of this gene from genomic DNA in patients whose clinical or biochemical phenotypes suggest impaired copper transport.
- Splice Junction
- Adaptor Primer
- Copper Transport
- Menkes Disease
- Copper Chaperone
Copper is an essential trace element that plays a role in cellular respiration, antioxidant defense, neurotransmitter biosynthesis, connective tissue biosynthesis and pigment formation and is critical for the survival of all living organisms. A family of eukaryotic cytoplasmic proteins termed copper chaperones that bind copper ions and deliver them to specific cellular pathways was discovered recently . The first copper chaperone, ATX1, is a cytosolic protein involved in an tio xidant defense and iron uptake, in addition to copper trafficking in the yeast Saccharomyces cerevisiae [2, 3]. The human homolog of ATX1 was isolated by screening a liver cDNA library, and named HAH1 (for human ATX homolog 1) . This gene maps to chromosome 5q32 , and is referred to synonymously as ATOX1 [6, 7].
Biochemical studies of ATOX1/HAH1 [8, 9] indicate copper-dependent interaction between this protein and two human copper-transporting ATPases. These latter molecules, encoded by the genes ATP7A and ATP7B, function to convey copper through the secretory pathway of cells including thetrans-Golgi network. Mutations in ATP7A and ATP7B produce characteristic clinical phenotypes: Menkes disease and occipital horn syndrome, allelic X-linked recessive traits [10, 11], and Wilson disease, an autosomal recessive trait, respectively.
Interestingly, disruption of the murine homolog (Atox1) results in perinatal mortality and biochemical abnormalities similar to that observed in the brindled mice (Mobr), a mouse model for classical Menkes disease . These cumulative findings suggest that the ATOX1 and ATP7A gene products are each integral to mammalian copper transport, and that mutations in either could produce similar clinical and biochemical phenotypes. Because of our interest in the molecular basis of such phenotypes, we determined the intron-exon boundaries of ATOX1 to enable mutation screening from genomic DNA, and analyzed splice junctions and coding sequences in several relevant patients.
Genomic structure of ATOX1 and mutation analysis
Intron/Exon junctions of ATOX1. The nucleotide sequences of intron/exon junctions are shown by uppercase letters for exons and by lowercase letters for introns. The GT-AG conserved splice junction sequences are seen in all three introns.
Oligonucleotide primers used to amplify ATOX 1 coding sequences and splice junctions
Forward Primer (5'-3')
Reverse Primer (5'-3')
Characterization of the genomic structure of ATOX1 enables rapid and efficient mutation screening from genomic DNA. Identification and clinical/biochemical delineation of patients in whom alterations in ATOX1 are found will permit better understanding of the significance of this gene product in human trace metal metabolism. In addition, functional polymorphisms in ATOX1 may be relevant in terms of phenotypic modifier effects in these copper transport disorders.
In this study, we determined the genomic structure of ATOX1 to facilitate screening of this gene in patients with clinical and biochemical findings suggestive of disordered copper homeostasis.
Peripheral blood specimens or skin fibroblast cultures were obtained from two individuals diagnosed with classical Menkes disease on clinical and biochemical grounds, one patient with occipital horn syndrome , and one adult female with a history of chronic anemia, low serum copper and ceruloplasmin, and abnormal plasma catecholamine levels consistent with mild deficiency of dopamine-β-hydroxylase, a copper-requiring enzyme. Genomic DNA was isolated from white blood cells or fibroblasts using the Wizard® Genomic DNA Purification Kit (Promega) according to the manufacturer's instructions. The studies were approved by the NICHD and NINDS Institutional Review Boards.
Oligonucleotide primers for PCR amplification were designed from the published cDNA sequence of the human homologue of ATOX1 gene . Each PCR reaction contained a final concentration of 1X optimized PCR buffer J (Invitrogen), 500 nM each PCR primer, 200 μM dNTP and 1.5 U Taq DNA polymerase (Life Technologies Inc.). 200 ng of genomic DNA was added to the total volume of 50 μl PCR reaction. These PCR reactions were then denatured for 5 minutes at 94°C in a Perkin-Elmer 9700 thermocycler; followed by 35 cycles of 94°C for 30 seconds, 55°C for 45 seconds and 72°C for 2 minutes; then with a final extension of 72°C for 7 minutes. Oligonucleotide primer sequences used to amplify ATOX 1 coding sequences and splice junctions are shown in Table 2.
5' and 3' RACE
The rapid amplification of 5' and 3' ends of cDNA (RACE) was performed with Marathon-Ready™ cDNA kit (Clontech), which is essentially an uncloned library of adaptor-ligated double-stranded cDNA. Both 5'-and 3'-RACE reactions were primed with an internal gene-specific primer (GSP) and the Marathon adaptor primer (AP). The adaptor-ligated cDNA does not contain a binding site for the AP. During the first round of thermal cycling, the GSP is extended to the end of the adaptor, creating an AP binding site at the 5' (or 3') terminus of the cDNA. In subsequent cycles, both the AP and the GSP can bind, allowing exponential amplification of the cDNA of interest.
To amplify the intronic regions of ATOX1, long PCR amplifications were performed in volume of 50 μl reactions by using the Expand Long Template PCR system kit (Roche). Each reaction contained 2.5 U Taq and Pwo DNA polymerases, 1X supplied buffer with 2.25 mM MgCl2, 500 μM dNTP, 300 nM each forward and reverse primers and up to 500 ng genomic DNA. The reaction were optimized as follows: an initial denaturation for 2 minutes at 93°C, followed by 10 cycles of 93°C for 10 seconds, 65°C for 30 seconds and alternated with 68°C for 4 minutes. For the next 20 cycles, the temperature profile was modified by the addition of increments of 20 seconds to each extension step at 68°C. A 7 minutes final extension period at 68°C was incorporated after the last cycle of long PCR reaction.
Sequence analysis was performed on an ABI 377 automated DNA sequencer at the National Institute of Neurological Disorders and Stroke, National Institute of Health, DNA Sequencing Facility.
We thank C. Holmes and J. Nagle of NINDS for technical support, and A. DePaepe and B. Loeys for the fibroblast cell line from their patient .
- O'Halloran TV, Culotta VC: Metallochaperones, an intracellular shuttle service for metal ions. J Biol Chem. 2000, 275: 25057-25060. 10.1074/jbc.R000006200.View ArticlePubMedGoogle Scholar
- Lin S-J, Culotta VC: The ATX1 gene of Saccharomyces cerevisiae encodes a small metal homeostasis factor that protects cells against reactive oxygen toxicity. Proc Natl Acad Sci U S A. 1995, 92: 3784-3788.PubMed CentralView ArticlePubMedGoogle Scholar
- Lin S-J, Pufahl RA, Dancis A, O'Halloran TV, Culotta VC: A role for the Saccharomyces cerevisiae ATX1 gene in copper trafficking and iron transport. J Biol Chem. 1997, 272: 9215-9220. 10.1074/jbc.272.14.9215.View ArticlePubMedGoogle Scholar
- Klomp LW, Lin S-J, Yuan DS, Klausner RD, Culotta VC, Gitlin JD: Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J Biol Chem. 1997, 272: 9221-9226. 10.1074/jbc.272.14.9221.View ArticlePubMedGoogle Scholar
- Boultwood J, Strickson AJ, Jabs EW, Cheng J-F, Fidler C, Wainscoat JS: Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q-syndrome within 5q32, and immediately adjacent to the SPARC gene. Hum Genet. 2000, 106: 127-129. 10.1007/s004390051020.View ArticlePubMedGoogle Scholar
- Walker JM, Tsivkovskii R, Lutsenko S: Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity. J Biol Chem. 2002, 277: 27953-27959. 10.1074/jbc.M203845200.View ArticlePubMedGoogle Scholar
- Arnesano F, Banci L, Bertini I, Ciofi-Baffoni S, Molteni E, Huffman DL, O'Halloran TV: Metallochaperones and metal-transporting ATPases: a comparative analysis of sequences and structures. Genome Research. 2002, 12: 255-271. 10.1101/gr.196802.View ArticlePubMedGoogle Scholar
- Larin D, Mekios C, Das K, Ross B, Yang A-S, Gilliam TC: Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p. J Biol Chem. 1999, 274: 28497-28504. 10.1074/jbc.274.40.28497.View ArticlePubMedGoogle Scholar
- Hamza I, Schaefer M, Klomp LW, Gitlin JD: Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis. Proc Natl Acad Sci U S A. 1999, 96: 13363-13368. 10.1073/pnas.96.23.13363.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu P-C, McAndrew PE, Kaler SG: Rapid and robust screening of the Menkes disease/occipital horn syndrome gene. Genetic Testing. 2002, 6: 255-260. 10.1089/10906570260471778.View ArticlePubMedGoogle Scholar
- Kaler SG, Gallo L, Proud VK, Percy AK, Mark Y, Segal NA, Goldstein DS, Holmes CS, Gahl WA: Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nature Genetics. 1994, 8: 195-202. 10.1038/ng1094-195.View ArticlePubMedGoogle Scholar
- Hamza I, Faisst A, Prohaska J, Chen J, Gruss P, Gitlin JD: The metallochaperone ATOX1 plays a critical role in perinatal copper homeostasis. PNAS. 2001, 98: 6848-6852. 10.1073/pnas.111058498.PubMed CentralView ArticlePubMedGoogle Scholar
- DePaepe A, Loeys B, Devriendt K, Fryns JP: Occipital horn syndrome in a 2-year-old boy. Clinical Dysmorphology. 1999, 8: 179-183.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.